Speakers

Omid Vafa

CBO

Ancora Biotech

Ed Ha

Head of Chemistry & Bioconjugation

Angiex

Manish Hudlikar

Scientist, Chemistry & Bioconjugates

Angiex

Nancy K Pryer

CSO

Ambagon Therapeutics

Ryan Potts

Head of Induced Proximity Platform

Amgen

James Prudent

CEO

Centrose Pharma

Behnam Nabet

Assistant Professor

Fred Hutchinson Cancer Research Center

Greg Verdine

Co-Founder & CEO

Fog Pharma

Binghe Wang

Regents Professor and Georgia Research Alliance Eminent Scholar

Georgia State University

Christina Woo

Associate Professor

Harvard University

Charles Lin

SVP Biology

Kronos Bio

Anthony Rullo

Assistant Professor

McMaster University

Nan Ji

CEO

PAQ Therapeutics

Kevin Foley

CSO

Ranok Therapeutics

Benedict Cross

CTO

Phoremost

Matthew Disney

Professor

Scripps Research

Patti Giblin

VP

Revitope Oncology

Robert Hilgraf

Senior Director, Medicinal Chemistry

Revolution Medicines

Scott A. Kanner

Co-founder & Head of Platform Development

Stablix

Jerry Crabtree

David Korn Professor

Stanford University Medical School

Jesse J. Chen

Co-Founder & CTO

Triana Biomedicines

Goutham Narla

Professor of Internal Medicine and Human Genetics, Division Chief of Genetic Medicine

The University of Michigan

Nate Hathaway

Associate Professor

The University of North Carolina at Chapel Hill

George M. Burslem

Assistant Professor

University of Pennsylvania

Dan Nomura

Professor

University of California at Berkeley

Katarina Pance

PhD Candidate (Jim Wells Lab)

University of California, San Francisco

Mikołaj Słabicki

Group Leader, Cancer Program, Ebert Lab; Senior Staff Scientist

Broad Institute; Dana-Farber Cancer Institute

Hojong Yoon

Postdoctoral Associate - Ebert lab

Broad Institute of MIT & Harvard

Radosław Nowak

Senior Scientist

Fischer Lab, Group Leader at the Center for Protein Degradation

Shourya S. Roy Burman

Research Fellow, Dr. Eric Fischer’s lab

Dana-Farber Cancer Institute & Harvard Medical School

Liz Caine

Research Scientist

Promega